[go: up one dir, main page]

DE602005009016D1 - Orale suspension mit meloxicam - Google Patents

Orale suspension mit meloxicam

Info

Publication number
DE602005009016D1
DE602005009016D1 DE602005009016T DE602005009016T DE602005009016D1 DE 602005009016 D1 DE602005009016 D1 DE 602005009016D1 DE 602005009016 T DE602005009016 T DE 602005009016T DE 602005009016 T DE602005009016 T DE 602005009016T DE 602005009016 D1 DE602005009016 D1 DE 602005009016D1
Authority
DE
Germany
Prior art keywords
meloxicam
oral suspension
pain
acute
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602005009016T
Other languages
English (en)
Inventor
Caspar Peter Elisabet Biesmans
Spiegeleer Bart De
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34929998&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE602005009016(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Publication of DE602005009016D1 publication Critical patent/DE602005009016D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
DE602005009016T 2004-12-06 2005-12-02 Orale suspension mit meloxicam Expired - Lifetime DE602005009016D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04106318 2004-12-06
PCT/EP2005/056419 WO2006061351A1 (en) 2004-12-06 2005-12-02 Oral suspension comprising meloxicam

Publications (1)

Publication Number Publication Date
DE602005009016D1 true DE602005009016D1 (de) 2008-09-25

Family

ID=34929998

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005009016T Expired - Lifetime DE602005009016D1 (de) 2004-12-06 2005-12-02 Orale suspension mit meloxicam

Country Status (14)

Country Link
US (1) US7705000B2 (de)
EP (1) EP1824493B1 (de)
JP (1) JP2008523024A (de)
AT (1) ATE404206T1 (de)
AU (1) AU2005313365A1 (de)
CA (1) CA2586288A1 (de)
DE (1) DE602005009016D1 (de)
DK (1) DK1824493T3 (de)
ES (1) ES2313452T3 (de)
NO (1) NO20073419L (de)
PL (1) PL1824493T3 (de)
PT (1) PT1824493E (de)
TW (1) TW200635598A (de)
WO (1) WO2006061351A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1568369A1 (de) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam zur Behandlung von Atemwegserkrankungen bei Schweinen
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
GB2438287A (en) * 2006-05-19 2007-11-21 Norbrook Lab Ltd Stable aqueous suspension
WO2007135362A2 (en) * 2006-05-19 2007-11-29 Norbrook Laboratories Limited Stable aqueous suspension having palatable taste
WO2008009664A2 (en) * 2006-07-19 2008-01-24 Boehringer Ingelheim International Gmbh Treatment of pain
FR2911506B1 (fr) * 2007-01-18 2009-07-03 Ceva Sante Animale Sa Compositions pharmaceutiques destinees a une administration par voie orale sous forme de suspensions aqueuses stabilisees
US8999395B2 (en) 2007-02-09 2015-04-07 Ceva Sante Animale Pharmaceutical compositions for oral administration in the form of stabilised aqueous suspensions
US20150231156A1 (en) * 2007-11-13 2015-08-20 Meritage Pharma, Inc. Corticosteroid compositions
CA2735714A1 (en) * 2008-09-05 2010-03-11 Troy Laboratories Pty. Ltd. Treatment of neonate foals with meloxicam
DK4378443T3 (da) * 2009-10-12 2025-08-18 Boehringer Ingelheim Vetmedica Gmbh Beholdere til sammensætninger, der omfatter meloxicam
GB201006218D0 (en) * 2010-04-14 2010-06-02 Ayanda As Composition
GB201117858D0 (en) 2011-10-17 2011-11-30 Norbrook Lab Ltd Paste
PL239019B1 (pl) * 2017-07-14 2021-10-25 Aflofarm Farm Polska Spolka Z Ograniczona Odpowiedzialnoscia Kompozycja farmaceutyczna w postaci wodnego roztworu, korzystnie syropu, zawierająca pranobeks inozyny oraz glukonianu cynku oraz jej sposób otrzymywania
WO2019037757A1 (zh) * 2017-08-24 2019-02-28 江苏恒瑞医药股份有限公司 一种包含美洛昔康的可注射的药物组合物及其制备方法
US12059423B2 (en) 2018-05-11 2024-08-13 Nanjing Delova Biotech Co., Ltd. Meloxicam composition, pharmaceutical preparation and preparation method and use thereof
EA202190045A1 (ru) * 2018-06-15 2021-03-17 Янссен Фармацевтика Нв Составы/композиции, содержащие ибрутиниб
GB2585825B (en) * 2019-07-09 2023-03-22 Lexon Uk Holdings Ltd Suspending vehicle formulation
KR102530032B1 (ko) 2019-09-18 2023-05-09 정원구 반려동물용 현탁액 조성물 및 이의 제조방법
CN113143863A (zh) * 2020-01-22 2021-07-23 浙江贝灵生物医药有限公司 一种口服溶媒组合物及其制备方法与应用
CN112587497A (zh) * 2020-12-25 2021-04-02 苏州中化药品工业有限公司 一种美洛昔康混悬液胶囊剂及其制备方法
CN115634198A (zh) * 2021-07-20 2023-01-24 浙江贝灵生物医药有限公司 用于水难溶性物质的溶媒组合物及其制备方法与应用
CN116327711B (zh) * 2022-01-18 2026-01-23 中国人民解放军军事科学院军事医学研究院 一种生物利用度高的美洛昔康纳米晶组合物及其应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ234143A (en) 1989-06-28 1991-10-25 Mcneil Ppc Inc Aqueous pharmaceutical suspension formulation for administering substantially insoluble pharmaceutical agents
US5272137A (en) 1992-02-14 1993-12-21 Mcneil-Pfc, Inc. Aqueous pharmaceutical suspension for pharmaceutical actives
IT1286496B1 (it) * 1996-11-20 1998-07-15 Leetrim Ltd Dublin Composizione farmaceutica orale ad attivita' antipiretica,analgesica ed antiinfiammatoria
WO1999009988A1 (en) * 1997-08-27 1999-03-04 Hexal Ag New pharmaceutical compositions of meloxicam with improved solubility and bioavailability
EP0945131A1 (de) * 1998-03-27 1999-09-29 Boehringer Ingelheim Pharma KG Perorale Wirkstoff-Suspension
EP0945134A1 (de) 1998-03-27 1999-09-29 Boehringer Ingelheim Pharma KG Neue galenische Zubereitungsformen von Meloxicam zur oralen Applikation
AU754064B2 (en) * 1998-05-15 2002-11-07 Wakamoto Pharmaceutical Co., Ltd. Anti-inflammatory eye drops
DE10030345A1 (de) * 2000-06-20 2002-01-10 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen
ATE474559T1 (de) * 2001-06-01 2010-08-15 Pozen Inc Pharmazeutische zusammensetzungen für die koordinierte abgabe von nsaid
US7666876B2 (en) * 2002-03-19 2010-02-23 Vernalis (R&D) Limited Buprenorphine formulations for intranasal delivery
JP2004131495A (ja) * 2002-09-17 2004-04-30 Nippon Boehringer Ingelheim Co Ltd 非ステロイド系抗炎症剤の局所送達用医薬組成物
US20050095299A1 (en) * 2003-10-30 2005-05-05 Wynn David W. Controlled release analgesic suspensions

Also Published As

Publication number Publication date
ATE404206T1 (de) 2008-08-15
EP1824493B1 (de) 2008-08-13
PT1824493E (pt) 2008-11-18
ES2313452T3 (es) 2009-03-01
TW200635598A (en) 2006-10-16
NO20073419L (no) 2007-07-03
US7705000B2 (en) 2010-04-27
AU2005313365A1 (en) 2006-06-15
JP2008523024A (ja) 2008-07-03
EP1824493A1 (de) 2007-08-29
WO2006061351A1 (en) 2006-06-15
CA2586288A1 (en) 2006-06-15
US20090221563A1 (en) 2009-09-03
PL1824493T3 (pl) 2009-01-30
DK1824493T3 (da) 2008-12-08

Similar Documents

Publication Publication Date Title
NO20073419L (no) Oral suspensjon omfattende meloxikam
HRP20110969T1 (en) Pimobendan to be used for the reduction of heart size in mammals suffering from heart failure
BRPI0918139A2 (pt) composição, alimento medicinal ou funcional, suplemento alimentar ou dietético para tratamento de distúrbios de desenvolvimento pervasivos com terapêuticos redox-ativos e uso
UY28933A1 (es) Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos
MY143407A (en) Indazole derivatives as inhibitors of hormone sensitive lipase
AU301949S (en) Dispenser
AU301948S (en) Dispenser
AU301952S (en) Dispenser
AU301946S (en) Dispenser
IT1392903B1 (it) Composizione comprendente un'associazione di principi attivi per uso nel trattamento topico della calvizie
AU302970S (en) Bracket comprising of two parts
AU303119S (en) Package
AU301947S (en) Dispenser
ITTO20040390A1 (it) Composizione, in particolare per uso farmaceutico, ad azione antiossidante, antinfiammatoria ed immunostimolante.
AU304505S (en) Lancet device
AU300528S (en) Toothbrush
EA201071203A1 (ru) Комбинациия дронедарона по меньшей мере с одним диуретиком, её применение в терапии
EA200801890A1 (ru) Средство для лечения шума в ушах
AU301951S (en) Dispenser
AU301950S (en) Dispenser
MXPA04000418A (es) Tratamiento de dolor cronico con 3-heterocicloxi- y -cicloalquiloxi-3-fenilpropanaminas.
WO2005113814A3 (en) Biomarkers of chronic pelvic pain syndrome
ITFI20060002U1 (it) "onivades" sedia che si trasforma in tavolino e viceversa.
TH0701005261A (th) แอนติ-Notch3 อะโกนิสต์ แอนติบอดีตัวใหม่และการใช้งานในการป้องกันและการบำบัดโรคที่เกี่ยวข้องกับ Notch3
UA10952U (uk) Спосіб корекції розкладів мікроциркуляції та гемостазу у хворих на хронічний стеатогепатит із синдромом інсулінорезистентності

Legal Events

Date Code Title Description
8363 Opposition against the patent